Paracelsus Medizinische Privatuniversität (PMU)

Forschung & Innovation
Publikationen

Durvalumab after Sequential High Dose Chemoradiotherapy versus Standard of Care (SoC) for Stage III NSCLC: A Bi-Centric Trospective Comparison Focusing on Pulmonary Toxicity.

#2022
#Cancers

PMU Autor*innen
Romana Wass, Brane Grambozov, Felix Sedlmayer, Michael Studnicka, Franz Zehentmayr

Alle Autor*innen
Romana Wass, Maximilian Hochmair, Bernhard Kaiser, Brane Grambozov, Petra Feurstein, Gertraud Weiß, Raphaela Moosbrugger, Felix Sedlmayer, Bernd Lamprecht, Michael Studnicka, Franz Zehentmayr

Fachzeitschrift
Cancers

Kurzfassung

Keywords

SURVIVAL, RADIOTHERAPY, CONSOLIDATION, CHEMORADIATION, PHASE-III, CELL LUNG-CANCER, CONCURRENT, INHIBITOR-RELATED PNEUMONITIS, REAL-WORLD DATA, RTOG 0617